Proteomics International Laboratories

Proteomics International Laboratories FCF Yield

The Free Cash Flow Yield of Proteomics International Laboratories (PIQ.AX) as of Nov 22, 2026 is -12.08 %. In the previous year, Free Cash Flow Yield was -10.17 % — a change of 18.82% (lower).

FCF Yield

-12.08 %

YoY

18.82%

Last updated:

Free Cash Flow Yield of Proteomics International Laboratories is 2026 -12.08 % . Free Cash Flow Yield of Proteomics International Laboratories was 2025 -10.17 % . It decreases by 18.82% lower compared to the previous year.

The Proteomics International Laboratories FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2019
-2.61 AUD
Jan 1, 2020
-3.02 AUD
Jan 1, 2021
-3.70 AUD
Jan 1, 2022
-5.62 AUD
Jan 1, 2023
-10.59 AUD
Jan 1, 2024
-9.19 AUD
Jan 1, 2025
-10.17 AUD
Jan 1, 2026
-12.08 AUD
The Proteomics International Laboratories FCF Yield history
YEARFCF YieldYoY
-12.08 %+18.82%
-10.17 %+10.63%
-9.19 %-13.23%
-10.59 %+88.34%
-5.62 %+51.99%
-3.70 %+22.51%
-3.02 %+15.58%
-2.61 %+50.31%
-1.74 %-29.88%
-2.48 %+6.20%
-2.33 %+120.34%
-1.06 %+103.45%
-0.52 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Proteomics International Laboratories Stock analysis

What does Proteomics International Laboratories do? Proteomics International Laboratories Ltd is a medical technology company based in Nedlands, Western Australia, listed on the stock exchange in April 2015. Operating within the health care sector, the firm specializes in predictive diagnostics and bio-analytical services, focusing on the study of protein structure and function. It develops and commercializes diagnostic tests for chronic diseases, particularly diabetic kidney disease. The company operates three unified business units: PromarkerD, which offers a blood test to assess DKD risk in type 2 diabetes patients; Diagnostics, which utilizes the Promarker platform to discover and validate protein biomarkers; and Analytical Services, which employs a proteomics-based technology platform to test and validate the protein composition of various products. Proteomics International Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Proteomics International Laboratories stock

Free Cash Flow Yield of Proteomics International Laboratories is -12.08 % in 2026.

Free Cash Flow Yield of Proteomics International Laboratories changed from -10.17 % to -12.08 %, representing a 18.82% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Proteomics International Laboratories since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Proteomics International Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Proteomics International Laboratories

All Key Metrics — Proteomics International Laboratories